SCHEMBL22650914

SCHEMBL22650914

CCCn1c2ccccc2c2cc(Nc3ccnc(Cl)n3)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAC1 P63000 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ MAPT P10636 9/20 0.43
▸ POLB P06746 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ CREBBP Q92793 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ LMNA P02545 4/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ USP2 O75604 2/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPY5R Q15761 2/20 0.39
▸ CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15064233 0.91 RAC1 (0.57) RAC1ALDH1A1HPGDMAPTPOLB
SCHEMBL20945450 0.75 MAPT (0.57) RAC1ALDH1A1HPGDMAPTPOLB
SCHEMBL20945473 0.72 RAC1 (0.69) RAC1ALDH1A1HPGDMAPTPOLB
SCHEMBL16229866 0.71 RAC1 (0.39) RAC1MAPTPOLBTSHRMAPK1
SCHEMBL20966330 0.71 RAC1 (0.67) RAC1ALDH1A1HPGDMAPTPOLB
SCHEMBL1921889 0.71 ALDH1A1 (0.60) ALDH1A1HPGDMAPTTSHRMAPK1
SCHEMBL15466121 0.70 SYK (0.53) ALDH1A1HPGDMAPTPOLBHTT
SCHEMBL12185529 0.70 CDC7 (0.46) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL18792269 0.70 CDC7 (0.73) ALDH1A1HPGDMAPTCREBBPCDC7
SCHEMBL28266232 0.70 ALDH1A1 (0.56) ALDH1A1HPGDMAPTMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB RAC1 6/4885ALDH1A1 3580/4885HPGD 898/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS RAC1 7/4885ALDH1A1 3604/4885HPGD 786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback